[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1869065T3 - Fremgangsmåde til kromatografi med svag opdeling - Google Patents

Fremgangsmåde til kromatografi med svag opdeling Download PDF

Info

Publication number
DK1869065T3
DK1869065T3 DK06738028.7T DK06738028T DK1869065T3 DK 1869065 T3 DK1869065 T3 DK 1869065T3 DK 06738028 T DK06738028 T DK 06738028T DK 1869065 T3 DK1869065 T3 DK 1869065T3
Authority
DK
Denmark
Prior art keywords
partition chromatography
weak partition
weak
chromatography
partition
Prior art date
Application number
DK06738028.7T
Other languages
English (en)
Inventor
Tim Iskra
Ranganathan Godavarti
Tianning Yu
James Edward Booth
Suresh Vunnum
Paul Brown
Shujun Sun
Jon Coffman
Brian D Kelley
Mary Beth Switzer
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36992346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1869065(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK1869065T3 publication Critical patent/DK1869065T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/30—Partition chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK06738028.7T 2005-03-11 2006-03-10 Fremgangsmåde til kromatografi med svag opdeling DK1869065T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66043705P 2005-03-11 2005-03-11
PCT/US2006/008919 WO2006099308A2 (en) 2005-03-11 2006-03-10 A method of weak partitioning chromatography

Publications (1)

Publication Number Publication Date
DK1869065T3 true DK1869065T3 (da) 2020-06-08

Family

ID=36992346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06738028.7T DK1869065T3 (da) 2005-03-11 2006-03-10 Fremgangsmåde til kromatografi med svag opdeling

Country Status (21)

Country Link
US (3) US8067182B2 (da)
EP (1) EP1869065B1 (da)
JP (1) JP5199063B2 (da)
KR (2) KR101482791B1 (da)
CN (2) CN101175765A (da)
AU (1) AU2006223180B2 (da)
BR (1) BRPI0608584B8 (da)
CA (1) CA2601062C (da)
CR (1) CR9377A (da)
DK (1) DK1869065T3 (da)
ES (1) ES2797480T3 (da)
HK (1) HK1210476A1 (da)
HU (1) HUE049797T2 (da)
IL (1) IL185687A (da)
MX (1) MX2007011129A (da)
NO (1) NO20074443L (da)
PL (1) PL1869065T3 (da)
PT (1) PT1869065T (da)
RU (1) RU2457214C2 (da)
SI (1) SI1869065T1 (da)
WO (1) WO2006099308A2 (da)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101482791B1 (ko) * 2005-03-11 2015-01-21 와이어쓰 엘엘씨 약한 분배성 크로마토그래피법
EP2069387A4 (en) * 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
JP2010501623A (ja) 2006-08-28 2010-01-21 アレス トレーディング ソシエテ アノニム Ｆｃ含有タンパク質の精製法
TW200821026A (en) * 2006-09-08 2008-05-16 Wyeth Corp Arginine wash in protein purification using affinity chromatography
MY185887A (en) 2006-09-13 2021-06-14 Abbvie Inc Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN104152395B (zh) * 2006-11-08 2020-03-10 惠氏公司 合理设计的细胞培养基
SI2565206T1 (sl) * 2007-10-30 2016-07-29 Genentech, Inc. Čiščenje protitelesa s kationsko izmenjevalno kromatografijo
WO2009092010A1 (en) * 2008-01-18 2009-07-23 Gagnon Peter S Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography
JP5666447B2 (ja) † 2008-08-14 2015-02-12 ジェネンテック， インコーポレイテッド 常在性タンパク質置換イオン交換メンブレンクロマトグラフィを用いた混入物除去方法
US20100069617A1 (en) * 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
EP2326658A4 (en) * 2008-09-12 2013-04-10 Ge Healthcare Bio Sciences Ab IMPROVED PROTEIN-AGGREGATE SEPARATION WITH MULTIMODAL ANION EXCHANGERS IN THE PRESENCE OF ZWITTERIONS EXCLUDED FROM THE PROTEIN
CA2738499A1 (en) 2008-10-20 2010-04-29 Abbott Laboratories Viral inactivation during purification of antibodies
RU2520838C2 (ru) 2008-10-20 2014-06-27 Эббви Инк Выделение и очистка антител с использованием аффинной хроматографии на основе белка а
RU2481824C2 (ru) 2008-10-29 2013-05-20 Аблинкс Н.В Препараты однодоменных антигенсвязывающих молекул
US10118962B2 (en) 2008-10-29 2018-11-06 Ablynx N.V. Methods for purification of single domain antigen binding molecules
ES2488542T3 (es) 2008-12-22 2014-08-27 F. Hoffmann-La Roche Ag Purificación de inmunoglobulinas
PL3272764T3 (pl) 2009-12-18 2024-06-10 Novartis Ag Sposób chromatografii powinowactwa
US8951807B2 (en) 2010-01-15 2015-02-10 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
MX344248B (es) 2010-05-25 2016-12-09 Genentech Inc * Metodos de purificacion de polipeptidos.
US20130096284A1 (en) * 2010-06-21 2013-04-18 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
US9428546B2 (en) 2010-07-30 2016-08-30 Pfizer Inc. Tandem purification of proteins
US8895707B2 (en) 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
AU2011329053A1 (en) 2010-11-15 2013-06-06 Biogen Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
JP5881744B2 (ja) 2011-02-02 2016-03-09 バイオ−ラッド ラボラトリーズ インコーポレーティッド アルカリ溶液でのアパタイトの表面中和方法
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013013193A1 (en) 2011-07-20 2013-01-24 Zepteon, Incorporated Polypeptide separation methods
WO2013067301A1 (en) 2011-11-02 2013-05-10 Genentech, Inc. Overload and elute chromatography
SG10201701224UA (en) 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
WO2013180933A1 (en) 2012-05-30 2013-12-05 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
KR20150027060A (ko) * 2012-05-31 2015-03-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 다중 모드의 기능성들을 갖는 입자들로 면역글로불린 g 조제물들의 크로마토그래피 정제
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201504249XA (en) 2012-09-02 2015-07-30 Abbvie Inc Methods to control protein heterogeneity
EP2931400B1 (en) 2012-12-14 2021-07-07 Cytiva BioProcess R&D AB Method for cleaning of packed bed chromatography columns
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
ES2674697T5 (es) * 2013-03-14 2022-04-19 Amgen Inc Eliminación de ligando de purificación por afinidad filtrado
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014145744A1 (en) 2013-03-15 2014-09-18 Alder Biopharmaceuticals, Inc. Antibody purification and purity monitoring
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
CA2920686C (en) 2013-09-13 2022-12-06 Genentech, Inc. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
MY176026A (en) 2013-09-13 2020-07-22 Genentech Inc Methods and composions comprising purified recombinant polypeptides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN105980047B (zh) 2013-12-12 2019-01-04 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
EP3157689B1 (en) 2014-06-23 2021-04-28 Bio-Rad Laboratories, Inc. Apatite pretreatment
EP3157551B1 (en) 2014-06-23 2023-02-15 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
WO2018022628A1 (en) 2016-07-25 2018-02-01 Cephalon, Inc. Affinity chromatography wash buffer
EP3769083A1 (en) 2018-03-21 2021-01-27 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
JP6951051B2 (ja) * 2018-05-24 2021-10-20 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 吸着剤の生産方法
US20220267369A1 (en) * 2018-07-25 2022-08-25 Merck Sharp & Dohme Corp. Methods of separating host cell lipases from a production protein in chromatographic processes
US20220135619A1 (en) 2019-02-24 2022-05-05 Bristol-Myers Squibb Company Methods of isolating a protein
EP3941607A1 (en) 2019-03-21 2022-01-26 Codiak BioSciences, Inc. Process for preparing extracellular vesicles
CN115023276A (zh) * 2020-01-29 2022-09-06 默沙东有限公司 从抗-lag3抗体生产中分离宿主细胞脂肪酶的方法
WO2022066934A2 (en) 2020-09-23 2022-03-31 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
US20240241020A1 (en) 2020-09-23 2024-07-18 Lonza Sales Ag Process for preparing extracellular vesicles
AU2022332274A1 (en) 2021-08-23 2024-02-15 Genentech, Inc. Flow through cation exchange chromatography purification processes for antibody drug conjugates
WO2024145232A1 (en) * 2022-12-30 2024-07-04 Eli Lilly And Company Methods of dulaglutide purification using hydrophobic interaction chromatography

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029583A (en) * 1975-02-28 1977-06-14 Purdue Research Foundation Chromatographic supports and methods and apparatus for preparing the same
JPS63126826A (ja) 1986-11-14 1988-05-30 Asahi Chem Ind Co Ltd プラスミノ−ゲン活性化因子誘導物質
US5451662A (en) 1987-10-23 1995-09-19 Schering Corporation Method of purifying protein
ATE121418T1 (de) * 1987-10-23 1995-05-15 Schering Corp Verfahren zur proteinreinigung.
US4983722A (en) * 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
ES2064412T3 (es) 1988-10-26 1995-02-01 American Cyanamid Co Procedimiento para reducir el contenido de aglomerado de materiales tipo hormona del crecimiento.
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin
US5264555A (en) 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
FR2703049B1 (fr) 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
EP0701566A1 (en) * 1994-04-01 1996-03-20 Unisyn Technologies, Inc. High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
RU2094077C1 (ru) * 1996-07-23 1997-10-27 Акционерное общество закрытого типа "Фосфосорб" Хроматографический способ выделения альфа-фетопротеина
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
US6504013B1 (en) 2000-02-01 2003-01-07 Idexx Laboratories, Inc. Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
AU6254799A (en) 1998-09-16 2000-04-03 Tanox, Inc. Anti-ige gene therapy
ATE266672T1 (de) 1998-12-30 2004-05-15 Folke Tjerneld Trennungsmethode unter verwendung von flüssig- flüssig partition
JP4363986B2 (ja) 2001-12-21 2009-11-11 イミュネックス・コーポレーション タンパク質の精製方法
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1601697B1 (en) 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
JP4496168B2 (ja) * 2003-07-28 2010-07-07 株式会社リバース・プロテオミクス研究所 非特異的物質の除去方法
CA2542951C (en) 2003-10-24 2016-08-30 Abhinav A. Shukla Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
JP5004586B2 (ja) * 2003-10-27 2012-08-22 ワイス・エルエルシー ヒドロキシアパタイトクロマトグラフィーを用いる高分子量凝集体の取り出し
KR101482791B1 (ko) * 2005-03-11 2015-01-21 와이어쓰 엘엘씨 약한 분배성 크로마토그래피법

Also Published As

Publication number Publication date
EP1869065B1 (en) 2020-05-06
BRPI0608584B1 (pt) 2018-02-06
CR9377A (es) 2008-02-21
US20120138537A1 (en) 2012-06-07
CA2601062A1 (en) 2006-09-21
SI1869065T1 (sl) 2020-08-31
ES2797480T3 (es) 2020-12-02
EP1869065A2 (en) 2007-12-26
KR20130128020A (ko) 2013-11-25
US8067182B2 (en) 2011-11-29
WO2006099308A2 (en) 2006-09-21
IL185687A (en) 2015-05-31
PT1869065T (pt) 2020-06-18
US9144755B2 (en) 2015-09-29
RU2457214C2 (ru) 2012-07-27
HUE049797T2 (hu) 2020-10-28
US20070060741A1 (en) 2007-03-15
CA2601062C (en) 2016-08-02
NO20074443L (no) 2007-09-27
CN104610422A (zh) 2015-05-13
MX2007011129A (es) 2007-11-06
RU2007132851A (ru) 2009-04-20
WO2006099308A3 (en) 2007-10-25
BRPI0608584A2 (pt) 2010-01-19
JP2008533473A (ja) 2008-08-21
AU2006223180B2 (en) 2011-11-24
PL1869065T3 (pl) 2020-09-21
AU2006223180A1 (en) 2006-09-21
HK1210476A1 (en) 2016-04-22
KR20070121667A (ko) 2007-12-27
KR101660575B1 (ko) 2016-09-27
IL185687A0 (en) 2008-01-06
BRPI0608584B8 (pt) 2021-05-25
CN101175765A (zh) 2008-05-07
JP5199063B2 (ja) 2013-05-15
US20070054390A1 (en) 2007-03-08
EP1869065A4 (en) 2012-07-04
KR101482791B1 (ko) 2015-01-21

Similar Documents

Publication Publication Date Title
DK1869065T3 (da) Fremgangsmåde til kromatografi med svag opdeling
FIC20230027I1 (fi) Tremelimumabi
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
CY2013044I2 (el) Δικυκλικες ετεροαρυλ ενωσεις
DK1941026T3 (da) Fremgangsmåder til fremstilling af protein under anvendelse af anti-senescensforbindelser
ATE483732T1 (de) Madcam-antikörper
DK2902690T3 (da) Anomalidetektor til rørledninger
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
DE602006012689D1 (de) Überprüfungsverfahren
ITMI20042238A1 (it) Composti per fluoropolirterei
DK1989189T3 (da) Adsorbenter til proteinoprensning
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
DK1943240T3 (da) Kemisk fremgangsmåde
DE602006001141D1 (de) Azimuth-ausgerichtete NMR-Proben
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1955066T3 (da) Membran-assay-fremgangsmåde
DE602005015817D1 (de) Chromatographische Säulen